-
Image Credit: Alberto G. -
Recent Posts
- Forced to Flee: Humanitarian Disasters Leave Women at Higher Risk
- Looking for $2 Trillion
- Is Viral Load Testing for HIV a Realistic Strategy in Developing Countries?
- Vaccine Hesitancy: A Call for Papers from PLOS Currents: Outbreaks
- Drugs for the Poor, Drugs for the Rich: Why the Current R&D Model Doesn’t Deliver
- Is the American Health Profession Ignoring a Human Rights Issue Hiding in Plain Sight?
Topics
Africa antimicrobial drugs antiretroviral treatment cardiovascular health child health china clinical trials developing world diarrhea environment Ghostwriting global burden of disease global health guidelines health costs health information health policy health systems HIV HIV/AIDS influenza LMICs malaria maternal and perinatal health maternal health medical literature medical students Mental Health mortality MSF neglected tropical diseases open access pharmaceutical industry Policy public health reporting research ethics sanitation sub-saharan Africa systematic reviews tobacco tuberculosis vaccine water WHO
Blog Archives
How a Free Trade Agreement Threatens Your Health and the Health of the People You Care About
Category: General
Tagged antiretroviral treatment, developing world, global health, health costs, health systems, pharmaceutical industry, Policy
Comments Off
This Week in PLOS Medicine: Maternal Health Collection, Pharmaceutical Industry, Burden of the 2009 Influenza Pandemic, & Poverty and HIV Stigma
Category: PLoS Medicine Week by Week
Tagged break the cycle, call for papers, clinicians, conflicts of interest, global burden of disease, HIV, HIV stigma, influenza, maternal health, mortality, pandemic, pharmaceutical industry, poverty
Comments Off
This Week in PLOS Medicine: Pharma Patent Extension, Serum Iron & Parkinson’s Disease, & Household Air Pollution
Category: PLoS Medicine Week by Week
Tagged air pollution, big pharma, cookstoves, health costs, household air pollution, Iron, Parkinson Disease, Parkinson's disease, pharmaceutical industry, PLoS Medicine Week by Week
Comments Off
Demonstrating Progress: Building a More Equitable Global R&D System
Category: Access, Neglected Diseases
Tagged developing world, global burden of disease, global health, health policy, pharmaceutical industry
Comments Off
From What We Know to What We Do: Now is the Time for Governments to Fix a Failing System for Drug Development
Category: Neglected Diseases
Tagged developing world, global health, health policy, health systems, medical students, neglected tropical diseases, pharmaceutical industry, Policy
Comments Off
European Court is on the Wrong Side on Patient Safety
Category: Access, General
Tagged clinical trials, health policy, pharmaceutical industry, Policy, reporting
8 Comments
Vaccines in Developing Countries: Why the High Prices?
Category: MSF
Tagged developing world, global health, health policy, MSF, pharmaceutical industry, Vaccines
Comments Off